Company news
Array Technologies, Inc. news in 2019
Array Technologies, Inc.'s news releases, calls and decks from 2019, newest first.
Array BioPharma Announces Interim Analysis Results from the BEACON CRC Trial of BRAFTOVI + MEKTOVI + Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer at the ESMO 21st World Congress on Gastrointestinal Cancer
July 5, 2019
Array BioPharma to Present Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI + MEKTOVI + Cetuximab for the Treatment of BRAFV600E- Mutant Metastatic Colorectal Cancer at the ESMO 21st World Congress on Gastrointestinal Cancer
June 24, 2019
Pfizer to Acquire Array BioPharma
June 16, 2019
Array BioPharma to Present at the Goldman Sachs 40 Annual Global Healthcare Conference
June 3, 2019
Array BioPharma to Present at the Jefferies 2019 Global Healthcare Conference
May 28, 2019
Array BioPharma Announces Presentation of Updated Overall Survival from the Phase 3 COLUMBUS Trial of BRAFTOVI + MEKTOVI in advanced BRAF-mutant Melanoma at 2019 ASCO Annual Meeting
May 28, 2019